Rigel Pharmaceuticals RIGL Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Assets, Net of Valuation Allowance at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsNet.
The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's deferred tax assets, net of valuation allowance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's deferred tax assets, net of valuation allowance?
- Rigel Pharmaceuticals (RIGL) reported deferred tax assets, net of valuation allowance of $245.85M in Q4 2025.